Lebanon imports roughly 95% of its pharmaceuticals, so the post-2019 currency and import shocks translated quickly into shortages. A 2025 national study of hospital pharmacists found that shortages drove patient-level costs up by about 86% on average — making smart sourcing critical.
Brand vs. generic — what to know
- A generic contains the same active molecule, dose, route and indication as the original.
- Generics typically cost at least 30% less in Lebanon.
- Pharmacists may substitute under the Order of Pharmacists (OPL) dispensing guidelines, but the prescribing doctor can mark "non-substitutable" when clinically required (narrow therapeutic index drugs, epilepsy medication, biologicals).
Practical steps when your usual drug is unavailable
- Ask the pharmacist for a registered Lebanese-market alternative — same molecule, different brand.
- If none, ask the pharmacist to call the manufacturer's distributor for an ETA.
- Call your treating doctor before switching molecule classes (e.g., from ARB to ACE inhibitor) — never self-substitute on your own.
- Confirm with the pharmacist the source, expiry, and that the packaging carries the MoPH stamp.
Warning signs of unsafe sources
- No box, no insert, packaging in a language other than the registered import language.
- Pricing dramatically below market — counterfeit drugs are a real risk.
- Sales via WhatsApp or social-media groups outside licensed pharmacies.
Chronic-disease patients
The Ministry of Public Health covers selected chronic-disease drugs (cancer, dialysis, organ transplant, some others) through its dispensing programme. Always renew well before you run out and keep at least a 2-week buffer.
